Polyphenols: Natural Food-Grade Biomolecules for the Treatment of Nervous System Diseases from a Multi-Target Perspective

被引:0
作者
Wu, Xinchen [1 ]
Zhou, Yang [1 ]
Xi, Yujiang [1 ]
Zhou, Haimei [2 ]
Tang, Zhengxiu [2 ]
Xiong, Lei [1 ]
Qin, Dongdong [2 ,3 ]
机构
[1] Yunnan Univ Chinese Med, Sch Clin Med 1, Kunming 650500, Peoples R China
[2] Yunnan Univ Chinese Med, Sch Basic Med Sci, Kunming 650500, Peoples R China
[3] Yunnan Univ Chinese Med, Key Lab Tradit Chinese Med Prevent & Treatment Neu, Kunming 650500, Peoples R China
基金
中国国家自然科学基金;
关键词
polyphenols; nervous system diseases; autism-spectrum disorders; anxiety disorders; depression; sleep disorders; OXIDATIVE STRESS; ANXIETY; AUTISM; ACID; DISORDER; CHILDREN; MITOCHONDRIAL; RESVERATROL; DYSFUNCTION; ADULTS;
D O I
10.3390/ph17060775
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Polyphenols are the most prevalent naturally occurring phytochemicals in the human diet and range in complexity from simple molecules to high-molecular-weight polymers. They have a broad range of chemical structures and are generally categorized as "neuroprotective", "anti-inflammatory", and "antioxidant" given their main function of halting disease onset and promoting health. Research has shown that some polyphenols and their metabolites can penetrate the blood-brain barrier and hence increase neuroprotective signaling and neurohormonal effects to provide anti-inflammatory and antioxidant effects. Therefore, multi-targeted modulation of polyphenols may prevent the progression of neuropsychiatric disorders and provide a new practical therapeutic strategy for difficult-to-treat neuropsychiatric disorders. Therefore, multi-target modulation of polyphenols has the potential to prevent the progression of neuropsychiatric disorders and provide a new practical therapeutic strategy for such nervous system diseases. Herein, we review the therapeutic benefits of polyphenols on autism-spectrum disorders, anxiety disorders, depression, and sleep disorders, along with in vitro and ex vivo experimental and clinical trials. Although their methods of action are still under investigation, polyphenols are still seldom employed directly as therapeutic agents for nervous system disorders. Comprehensive mechanistic investigations and large-scale multicenter randomized controlled trials are required to properly evaluate the safety, effectiveness, and side effects of polyphenols.
引用
收藏
页数:25
相关论文
共 142 条
  • [1] Resveratrol Improves Neuroimmune Dysregulation Through the Inhibition of Neuronal Toll-Like Receptors and COX-2 Signaling in BTBR T+ Itpr3tf/J Mice
    Ahmad, Sheikh F.
    Ansari, Mushtaq A.
    Nadeem, Ahmed
    Alzahrani, Mohammad Z.
    Bakheet, Saleh A.
    Attia, Sabry M.
    [J]. NEUROMOLECULAR MEDICINE, 2018, 20 (01) : 133 - 146
  • [2] Generalized Anxiety Disorder
    不详
    [J]. ANNALS OF INTERNAL MEDICINE, 2019, 170 (07) : ITC49 - ITC64
  • [3] Progress in the USA for autistic spectrum disorder
    不详
    [J]. LANCET, 2018, 391 (10132) : 1750 - 1750
  • [4] Dietary Plant Polyphenols: Effects of Food Processing on Their Content and Bioavailability
    Arfaoui, Leila
    [J]. MOLECULES, 2021, 26 (10):
  • [5] Mitochondrial Fatty Acid β-Oxidation and Resveratrol Effect in Fibroblasts from Patients with Autism Spectrum Disorder
    Barone, Rita
    Bastin, Jean
    Djouadi, Fatima
    Singh, Indrapal
    Karim, Mohammad Azharul
    Ammanamanchi, Amrit
    McCarty, Patrick John
    Delhey, Leanna
    Shannon, Rose
    Casabona, Antonino
    Rizzo, Renata
    Frye, Richard Eugene
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (06):
  • [6] Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism
    Bertolino, Bartolomeo
    Crupi, Rosalia
    Impellizzeri, Daniela
    Bruschetta, Giuseppe
    Cordaro, Marika
    Siracusa, Rosalba
    Esposito, Emanuela
    Cuzzocrea, Salvatore
    [J]. CNS NEUROSCIENCE & THERAPEUTICS, 2017, 23 (01) : 87 - 98
  • [7] Antioxidant Activity, Metabolism, and Bioavailability of Polyphenols in the Diet of Animals
    Beslo, Drago
    Golubic, Natasa
    Rastija, Vesna
    Agic, Dejan
    Karnas, Maja
    Subaric, Domagoj
    Lucic, Bono
    [J]. ANTIOXIDANTS, 2023, 12 (06)
  • [8] Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
    Bikbov, Boris
    Purcell, Carrie
    Levey, Andrew S.
    Smith, Mari
    Abdoli, Amir
    Abebe, Molla
    Adebayo, Oladimeji M.
    Afarideh, Mohsen
    Agarwal, Sanjay Kumar
    Agudelo-Botero, Marcela
    Ahmadian, Elham
    Al-Aly, Ziyad
    Alipour, Vahid
    Almasi-Hashiani, Amir
    Al-Raddadi, Rajaa M.
    Alvis-Guzman, Nelson
    Amini, Saeed
    Andrei, Tudorel
    Andrei, Catalina Liliana
    Andualem, Zewudu
    Anjomshoa, Mina
    Arabloo, Jalal
    Ashagre, Alebachew Fasil
    Asmelash, Daniel
    Ataro, Zerihun
    Atout, Maha Moh'd Wahbi
    Ayanore, Martin Amogre
    Badawi, Alaa
    Bakhtiari, Ahad
    Ballew, Shoshana H.
    Balouchi, Abbas
    Banach, Maciej
    Barquera, Simon
    Basu, Sanjay
    Bayih, Mulat Tirfie
    Bedi, Neeraj
    Bello, Aminu K.
    Bensenor, Isabela M.
    Bijani, Ali
    Boloor, Archith
    Borzi, Antonio M.
    Camera, Luis Alberto
    Carrero, Juan J.
    Carvalho, Felix
    Castro, Franz
    Catala-Lopez, Ferran
    Chang, Alex R.
    Chin, Ken Lee
    Chung, Sheng-Chia
    Cirillo, Massimo
    [J]. LANCET, 2020, 395 (10225) : 709 - 733
  • [9] Oxidative Stress in Autism Spectrum Disorder
    Bjorklund, Geir
    Meguid, Nagwa A.
    El-Bana, Mona A.
    Tinkov, Alexey A.
    Saad, Khaled
    Dadar, Maryam
    Hemimi, Maha
    Skalny, Anatoly V.
    Hosnedlova, Bozena
    Kizek, Rene
    Osredkar, Josko
    Urbina, Mauricio A.
    Fabjan, Teja
    El-Houfey, Amira A.
    Kaluzna-Czaplinska, Joanna
    Gatarek, Paulina
    Chirumbolo, Salvatore
    [J]. MOLECULAR NEUROBIOLOGY, 2020, 57 (05) : 2314 - 2332
  • [10] Bono Amanda D, 2021, Handb Clin Neurol, V183, P175, DOI 10.1016/B978-0-12-822290-4.00015-3